Worldview
Biotechnology innovation requires investment and the Scientific American Worldview Scorecard, released at the 2013 BIO International Convention, can predict where investment goes. A recent analysis indicates that the ranking of countries in this Scorecard correlates with global investment.
BioCentury This Week
6 YEARS OF AVANDIA - FDA's Janet Woodcock, GSK's Murray Stewart, and Robert Califf and Kenneth Mahaffey from Duke University dissect the Avandia story - and what, if anything, has been learned about post-market oversight.
Gene Patent Decision
The Supreme Court's decision regarding Myriad Genetics' patent claims on isolated DNA molecules represents a troubling departure from decades of judicial and Patent and Trademark Office precedent supporting the patentability of DNA molecules that mimic naturally-occurring sequences.
Biologic Substitution
BIO and the Delaware BioScience Association commend the Delaware State Senate for introducing legislation designed to address the regulatory issues related to the interchangeability of biological medicines.
2013 Farm Bill
BIO thanks Sens. Debbie Stabenow (D-Mich.) and Thad Cochran (R-Miss.) and applauds the Senate for including mandatory funding for Energy Title programs and eligibility for renewable chemicals in Farm Bill reauthorization legislation.
- Worldview
- BioCentury This Week
- Gene Patent Decision
- Biologic Substitution
- 2013 Farm Bill
What is Biotechnology?
At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the health of our planet. We have used the biological processes of microorganisms for more than 6,000 years to make useful food products, such as bread and cheese, and to preserve dairy products.
Want to learn more about how biotechnology is healing, feeding and fueling the world?
Highlights
The bioscience industry is one of the most innovative and important economic drivers in the...
|
In the next several months, the president and members of Congress will decide whether to continue...
|
At a time when the global economy struggles to recover from a severe recession and uncertainty...
|
-
The BIO World Congress on Industrial Biotechnology is the world's largest industrial biotechnology event for business leaders, investors,...
-
Over the past nine years, BIO's semiannual IP Counsels Committee Conference has become a popular and growing event among our members' IP...
-
BIO Investor Forum Join Us October 8-9, 2013 Registration is now open! Click here to register for the 2013 BIO Investor Forum. The BIO...
-
Registration for the 2013 BIO Convention in China Opens June 20th Join us November 11-13, 2013 at the China National Convention Center in...
-
Building Innovative Collaborations Across the Pacific The seventh annual Pacific Rim Summit on Industrial Biotechnology and Bioenergy is the...
Jim Greenwood on the Road:
Communicating the Biotechnology Message
Javascript is required to view this map.
Last Visited Location
Boston
Boston Irish Business Awards Breakfast, United States | May 29 2013
Jim Greenwood joined President and CEO of MassBio Bob Coughlin at the Boston Irish Business Awards Breakfast. Coughlin was recognized for his achievements in business while retaining his connection to Ireland. Learn more about the event.
Business Solutions Sponsor
